Fragments of alpha-1-antitrypsin in patients with severe COVID-19 and bacterial pulmonary sepsis

Clin Chem Lab Med. 2022 May 4;60(8):e187-e189. doi: 10.1515/cclm-2022-0361. Print 2022 Jul 26.

Authors

Arite Bigalke¹, Charles Neu^{2

3}, Ricardo Esper Treml^{2

3}, Sina M Coldewey^{2

3}, Michael Kiehntopf¹

Affiliations

¹ Institute of Clinical Chemistry and Laboratory Diagnostics and Integrated Biobank Jena (IBBJ), Jena University Hospital, Jena, Germany.
² Department of Anaesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
³ Septomics Research Centre, Jena University Hospital, Jena, Germany.

PMID: 35503554
DOI: 10.1515/cclm-2022-0361

No abstract available

Keywords: COVID; alpha-1-antitrypsin; inflammation; proteases.

Publication types

Letter
Comment

MeSH terms

COVID-19*
Humans
Sepsis* / complications
Sepsis* / diagnosis
alpha 1-Antitrypsin
alpha 1-Antitrypsin Deficiency*

Substances

alpha 1-Antitrypsin